137 related articles for article (PubMed ID: 14726692)
1. Inhibition of cdk1 by alsterpaullone and thioflavopiridol correlates with increased transit time from mid G2 through prophase.
Soni DV; Jacobberger JW
Cell Cycle; 2004 Mar; 3(3):349-57. PubMed ID: 14726692
[TBL] [Abstract][Full Text] [Related]
2. A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin.
McVean M; Weinberg WC; Pelling JC
Mol Carcinog; 2002 Jan; 33(1):36-43. PubMed ID: 11807956
[TBL] [Abstract][Full Text] [Related]
3. Loss of p53 induces M-phase retardation following G2 DNA damage checkpoint abrogation.
Minemoto Y; Uchida S; Ohtsubo M; Shimura M; Sasagawa T; Hirata M; Nakagama H; Ishizaka Y; Yamashita K
Arch Biochem Biophys; 2003 Apr; 412(1):13-9. PubMed ID: 12646262
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity.
Arita Y; Buffolino P; Coppock DL
Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525
[TBL] [Abstract][Full Text] [Related]
5. Novel positive feedback loop between Cdk1 and Chk1 in the nucleus during G2/M transition.
Enomoto M; Goto H; Tomono Y; Kasahara K; Tsujimura K; Kiyono T; Inagaki M
J Biol Chem; 2009 Dec; 284(49):34223-30. PubMed ID: 19837665
[TBL] [Abstract][Full Text] [Related]
6. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1.
Casagrande F; Darbon JM
Biochem Pharmacol; 2001 May; 61(10):1205-15. PubMed ID: 11322924
[TBL] [Abstract][Full Text] [Related]
7. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.
Jiang H; Luo S; Li H
J Biol Chem; 2005 May; 280(21):20651-9. PubMed ID: 15790566
[TBL] [Abstract][Full Text] [Related]
8. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
[TBL] [Abstract][Full Text] [Related]
10. Delta MEKK3:ER* activation induces a p38 alpha/beta 2-dependent cell cycle arrest at the G2 checkpoint.
Garner AP; Weston CR; Todd DE; Balmanno K; Cook SJ
Oncogene; 2002 Nov; 21(53):8089-104. PubMed ID: 12444545
[TBL] [Abstract][Full Text] [Related]
11. Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin.
Lepley DM; Pelling JC
Mol Carcinog; 1997 Jun; 19(2):74-82. PubMed ID: 9210954
[TBL] [Abstract][Full Text] [Related]
12. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.
Toyoshima-Morimoto F; Taniguchi E; Shinya N; Iwamatsu A; Nishida E
Nature; 2001 Mar; 410(6825):215-20. PubMed ID: 11242082
[TBL] [Abstract][Full Text] [Related]
13. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition.
Barboule N; Lafon C; Chadebech P; Vidal S; Valette A
FEBS Lett; 1999 Feb; 444(1):32-7. PubMed ID: 10037143
[TBL] [Abstract][Full Text] [Related]
14. S and G2 phase roles for Cdk2 revealed by inducible expression of a dominant-negative mutant in human cells.
Hu B; Mitra J; van den Heuvel S; Enders GH
Mol Cell Biol; 2001 Apr; 21(8):2755-66. PubMed ID: 11283255
[TBL] [Abstract][Full Text] [Related]
15. Paullones, a series of cyclin-dependent kinase inhibitors: synthesis, evaluation of CDK1/cyclin B inhibition, and in vitro antitumor activity.
Schultz C; Link A; Leost M; Zaharevitz DW; Gussio R; Sausville EA; Meijer L; Kunick C
J Med Chem; 1999 Jul; 42(15):2909-19. PubMed ID: 10425100
[TBL] [Abstract][Full Text] [Related]
16. 2-Substituted paullones: CDK1/cyclin B-inhibiting property and in vitro antiproliferative activity.
Kunick C; Schultz C; Lemcke T; Zaharevitz DW; Gussio R; Jalluri RK; Sausville EA; Leost M; Meijer L
Bioorg Med Chem Lett; 2000 Mar; 10(6):567-9. PubMed ID: 10741555
[TBL] [Abstract][Full Text] [Related]
17. Association of G1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells.
D'Anna JA; Valdez JG; Habbersett RC; Crissman HA
Radiat Res; 1997 Sep; 148(3):260-71. PubMed ID: 9291358
[TBL] [Abstract][Full Text] [Related]
18. Induction of differentiation accompanies inhibition of Cdk2 in a non-small cell lung cancer cell line.
Lee HR; Chang TH; Tebalt MJ; Senderowicz AM; Szabo E
Int J Oncol; 1999 Jul; 15(1):161-6. PubMed ID: 10375610
[TBL] [Abstract][Full Text] [Related]
19. Chemical inhibitors of cyclin-dependent kinases.
Meijer L
Prog Cell Cycle Res; 1995; 1():351-63. PubMed ID: 9552377
[TBL] [Abstract][Full Text] [Related]
20. CDK1 inhibition sensitizes normal cells to DNA damage in a cell cycle dependent manner.
Prevo R; Pirovano G; Puliyadi R; Herbert KJ; Rodriguez-Berriguete G; O'Docherty A; Greaves W; McKenna WG; Higgins GS
Cell Cycle; 2018; 17(12):1513-1523. PubMed ID: 30045664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]